Gene Set Size Count Z-Score P-Value Q-Value List of Genes

Gene Set Size Count Z-Score P-Value Q-Value List of Genes

Supplementary Data 2-1 Results from competitive pathway enrichment analysis based on genome-wide summary-level data of hsGWAS. Gene Set Size Count z-score p-value q-value List of Genes KEGG_ALLOGRAFT_ 38 36 12.6476 0.00E+00 0.00E+00 HLA-DRB5(4.11028); IL2(3.62922); HLA-E(3.27708); HLA-G(3.2749); HLA- REJECTION DQA2(3.16347); HLA-DRA(3.14994); HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); TNF(3.09414); HLA-DPB1(3.03922); HLA-DPA1(3.0355); HLA-A(3.02312); HLA-C(2.98835); HLA-DQB1(2.97025); HLA-B(2.95626); HLA- DQA1(2.94591); HLA-F(2.83254); HLA-DRB1(2.76738); HLA-DOA(2.72508); IFNG(1.74523); PRF1(1.46483); FASLG(1.10083); FAS(0.923795); HLA- DRB3(0.760622); CD80(0.436654); IL4(0.324564); CD40(0.271072); HLA- DRB4(0.0708609); IL12A(0.0685942); IL5(0.0659333); CD86(0.049911); CD28(- 0.16103); IL10(-0.165903); IL12B(-0.245281); GZMB(-0.268581); KEGG_GRAFT_VERSUS_HOS 42 37 12.6129 0.00E+00 0.00E+00 HLA-DRB5(4.11028); IL2(3.62922); HLA-E(3.27708); HLA-G(3.2749); HLA- T_DISEASE DQA2(3.16347); HLA-DRA(3.14994); HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); TNF(3.09414); HLA-DPB1(3.03922); HLA-DPA1(3.0355); HLA-A(3.02312); HLA-C(2.98835); HLA-DQB1(2.97025); HLA-B(2.95626); HLA- DQA1(2.94591); HLA-F(2.83254); HLA-DRB1(2.76738); HLA-DOA(2.72508); IL6(1.94139); IFNG(1.74523); PRF1(1.46483); FASLG(1.10083); FAS(0.923795); HLA-DRB3(0.760622); CD80(0.436654); IL1A(0.402186); KLRD1(0.29064); KIR3DL1(0.157683); HLA-DRB4(0.0708609); CD86(0.049911); CD28(-0.16103); GZMB(-0.268581); IL1B(-0.388308); KLRC1(-0.466394); KIR3DL2(-0.786806); KEGG_TYPE_I_DIABETES_ME 44 43 12.0019 0.00E+00 0.00E+00 HLA-DRB5(4.11028); IL2(3.62922); HLA-E(3.27708); HLA-G(3.2749); HLA- LLITUS DQA2(3.16347); HLA-DRA(3.14994); HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); TNF(3.09414); LTA(3.08913); HLA-DPB1(3.03922); HLA- DPA1(3.0355); HLA-A(3.02312); HLA-C(2.98835); HLA-DQB1(2.97025); HLA- B(2.95626); HLA-DQA1(2.94591); HLA-F(2.83254); HLA-DRB1(2.76738); HLA- DOA(2.72508); IFNG(1.74523); PRF1(1.46483); FASLG(1.10083); GAD1(0.975717); FAS(0.923795); HLA-DRB3(0.760622); ICA1(0.752093); CD80(0.436654); HSPD1(0.404551); IL1A(0.402186); PTPRN2(0.388508); HLA-DRB4(0.0708609); IL12A(0.0685942); CD86(0.049911); CPE(-0.0572665); CD28(-0.16103); IL12B(- 0.245281); GZMB(-0.268581); IL1B(-0.388308); GAD2(-0.416458); INS(- 0.642122); PTPRN(-0.757008); KEGG_AUTOIMMUNE_ 53 51 11.9818 0.00E+00 0.00E+00 HLA-DRB5(4.11028); IL2(3.62922); HLA-E(3.27708); HLA-G(3.2749); HLA- THYROID_DISEASE DQA2(3.16347); HLA-DRA(3.14994); HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); HLA-DPB1(3.03922); HLA-DPA1(3.0355); HLA-A(3.02312); HLA-C(2.98835); HLA-DQB1(2.97025); HLA-B(2.95626); HLA-DQA1(2.94591); HLA-F(2.83254); HLA-DRB1(2.76738); HLA-DOA(2.72508); IFNA1(2.57774); IFNA17(1.64472); IFNA7(1.62659); IFNA10(1.62315); IFNA16(1.61427); PRF1(1.46483); IFNA14(1.46285); TSHB(1.42533); IFNA13(1.4019); IFNA6(1.3785); FASLG(1.10083); FAS(0.923795); IFNA8(0.870525); HLA- DRB3(0.760622); CD80(0.436654); IL4(0.324564); IFNA21(0.297396); CD40(0.271072); CTLA4(0.235469); IFNA4(0.226331); IFNA2(0.151927); HLA- DRB4(0.0708609); IL5(0.0659333); CD86(0.049911); TPO(-0.0662216); IFNA5(- 0.102715); TG(-0.153394); CD28(-0.16103); IL10(-0.165903); GZMB(-0.268581); CGA(-0.403254); TSHR(-1.08937); KEGG_ANTIGEN_ 89 80 10.3794 0.00E+00 0.00E+00 HLA-DRB5(4.11028); HSPA1B(3.36842); HSPA1A(3.3411); HSPA1L(3.30303); PROCESSING_AND_PRESEN HLA-E(3.27708); HLA-G(3.2749); HLA-DQA2(3.16347); HLA-DRA(3.14994); TATION HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); LTA(3.08913); HLA-DPB1(3.03922); HLA-DPA1(3.0355); HLA-A(3.02312); TAP1(2.99505); HLA- C(2.98835); HLA-DQB1(2.97025); HLA-B(2.95626); HLA-DQA1(2.94591); TAP2(2.93098); HLA-F(2.83254); HLA-DRB1(2.76738); HLA-DOA(2.72508); IFNA1(2.57774); IFNA17(1.64472); IFNA7(1.62659); IFNA10(1.62315); IFNA16(1.61427); TAPBP(1.53511); IFNA14(1.46285); IFNA13(1.4019); IFNA6(1.3785); IFI30(1.11839); IFNA8(0.870525); HSPA6(0.860512); HLA- DRB3(0.760622); LGMN(0.751155); RFX5(0.731158); CTSS(0.725716); HSPA4(0.673791); HSPA5(0.578858); NFYB(0.53654); HSPA2(0.427194); IFNA21(0.297396); KLRD1(0.29064); IFNA4(0.226331); KIR2DL4(0.178735); KIR3DL1(0.157683); IFNA2(0.151927); HLA-DRB4(0.0708609); CANX(- 0.00786418); PSME3(-0.0268547); HSPA8(-0.0426388); PSME2(-0.0436557); RFXANK(-0.0511772); PSME1(-0.079645); IFNA5(-0.102715); CTSB(-0.128134); CIITA(-0.148118); RFXAP(-0.178394); NFYC(-0.287989); CREB1(-0.315765); PDIA3(-0.348713); CD74(-0.359131); CD8A(-0.391305); KLRC2(-0.405379); CALR(-0.437964); CD4(-0.44345); CD8B(-0.443911); KLRC1(-0.466394); KIR3DL3(-0.471068); B2M(-0.476766); KIR2DS4(-0.529479); KLRC4(-0.562774); KLRC3(-0.592427); HSP90AB1(-0.674748); HSP90AA1(-0.681845); KIR3DL2(- 0.786806); NFYA(-0.833691); KEGG_SYSTEMIC_LUPUS_ER 140 130 9.74006 0.00E+00 0.00E+00 HLA-DRB5(4.11028); HIST1H2AI(3.65052); HIST1H2BL(3.64688); YTHEMATOSUS HIST1H3H(3.64339); HIST1H2BM(3.33787); HIST1H2AJ(3.33787); HLA- DQA2(3.16347); HLA-DRA(3.14994); HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); TNF(3.09414); C2(3.05293); C4B(3.05007); C4A(3.05007); HLA-DPB1(3.03922); HLA-DPA1(3.0355); HLA-DQB1(2.97025); HLA- DQA1(2.94591); HLA-DRB1(2.76738); HLA-DOA(2.72508); H2AFY2(2.02561); HIST1H3J(2.00032); HIST1H2BO(1.99425); HIST1H2AM(1.99425); IFNG(1.74523); HIST1H2AG(1.66906); HIST1H2BJ(1.65621); HIST1H2AH(1.6501); HIST1H4I(1.61301); HIST1H2BK(1.56533); HIST1H2BN(1.48654); HIST1H4L(1.47987); HIST1H2AL(1.47987); HIST1H2AK(1.47651); HIST1H3I(1.47623); HIST1H4J(1.34966); HIST1H4K(1.34164); C9(1.18727); C6(1.1118); C1S(1.09855); HIST1H4D(1.03022); HIST1H2BG(1.01864); HIST1H2AE(1.01701); HIST1H2AD(1.00268); HIST1H2BF(0.999573); C8G(0.999052); HIST1H3D(0.998028); C1R(0.997817); HIST1H4E(0.996491); HIST1H2BD(0.969877); ACTN2(0.962041); HIST1H4C(0.940817); HIST1H2BE(0.886607); FCGR2B(0.823869); FCGR2A(0.817765); H3F3A(0.794914); GRIN2B(0.790131); HLA-DRB3(0.760622); HIST1H2BA(0.742792); HIST1H2AA(0.739847); HIST1H3C(0.718367); HIST1H2BB(0.718367); HIST1H4B(0.706147); HIST1H2AB(0.704646); HIST1H3B(0.701784); HIST1H2AC(0.586216); HIST1H2BC(0.578733); HIST1H4H(0.572592); H2AFY(0.536314); FCGR3B(0.471305); CD80(0.436654); H2AFJ(0.429568); HIST4H4(0.427884); FCGR2C(0.401133); ACTN4(0.360653); C5(0.360513); CD40(0.271072); GRIN2A(0.262373); H2AFZ(0.20518); H2AFX(0.153526); ACTN1(0.0709246); HLA-DRB4(0.0708609); SSB(0.070463); HIST1H3G(0.0698672); HIST1H2BI(0.0604719); CD86(0.049911); TROVE2(0.0439053); C3(0.0236471); HIST1H3F(-0.00841189); HIST1H4G(- 0.00841189); HIST1H2BH(-0.00963075); HIST1H3E(-0.0205535); ACTN3(- 0.034746); H2AFV(-0.0819867); HIST1H4F(-0.133493); CD28(-0.16103); IL10(- 0.165903); HIST3H2BB(-0.174075); HIST3H2A(-0.174075); HIST3H3(-0.174075); KEGG_VIRAL_ 73 68 8.21851 0.00E+00 0.00E+00 HLA-DRB5(4.11028); HLA-E(3.27708); HLA-G(3.2749); HLA-DQA2(3.16347); MYOCARDITIS HLA-DRA(3.14994); HLA-DOB(3.11438); HLA-DMB(3.09917); HLA- DMA(3.09615); HLA-DPB1(3.03922); HLA-DPA1(3.0355); HLA-A(3.02312); HLA- C(2.98835); HLA-DQB1(2.97025); HLA-B(2.95626); HLA-DQA1(2.94591); HLA- F(2.83254); LAMA2(2.79088); HLA-DRB1(2.76738); HLA-DOA(2.72508); ICAM1(2.37149); MYH14(2.15065); EIF4G2(1.86535); PRF1(1.46483); ABL1(1.23708); ITGB2(1.12695); EIF4G1(1.10593); SGCD(1.09625); RAC3(0.881826); CASP9(0.79633); HLA-DRB3(0.760622); SGCB(0.698544); RAC2(0.563748); MYH9(0.518042); CYCS(0.504235); ITGAL(0.494027); CD80(0.436654); DAG1(0.358283); CD40(0.271072); MYH13(0.179219); MYH11(0.129008); HLA-DRB4(0.0708609); CD86(0.049911); CAV1(-0.0447534); MYH6(-0.0488321); CXADR(-0.0676558); MYH1(-0.0678804); MYH2(- 0.102955); CD28(-0.16103); MYH10(-0.21898); FYN(-0.241479); ACTB(- 0.251508); MYH7(-0.293116); MYH3(-0.332542); ABL2(-0.340488); CD55(- 0.388429); CCND1(-0.401944); SGCG(-0.517643); CASP3(-0.541075); BID(- 0.589717); CASP8(-0.598201); MYH8(-0.602901); MYH4(-0.670849); MYH15(- 0.683912); EIF4G3(-0.722139); MYH7B(-0.761638); SGCA(-0.830816); RAC1(- 0.871829); ACTG1(-1.26763); KEGG_ASTHMA 30 29 8.05361 0.00E+00 0.00E+00 HLA-DRB5(4.11028); HLA-DQA2(3.16347); HLA-DRA(3.14994); HLA- DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); TNF(3.09414); HLA- DPB1(3.03922); HLA-DPA1(3.0355); HLA-DQB1(2.97025); HLA-DQA1(2.94591); HLA-DRB1(2.76738); HLA-DOA(2.72508); IL9(0.88924); HLA-DRB3(0.760622); IL13(0.436581); IL4(0.324564); CD40(0.271072); RNASE3(0.159919); HLA- DRB4(0.0708609); IL5(0.0659333); FCER1A(-0.124279); PRG2(-0.134005); IL10(- 0.165903); CCL11(-0.33936); IL3(-0.347172); FCER1G(-0.449948); EPX(- 0.508371); MS4A2(-0.867899); KEGG_INTESTINAL_ 48 47 7.58457 1.65E-14 2.29E-12 HLA-DRB5(4.11028); IL2(3.62922); HLA-DQA2(3.16347); HLA-DRA(3.14994); IMMUNE_NETWORK_FOR_I HLA-DOB(3.11438); HLA-DMB(3.09917); HLA-DMA(3.09615); HLA- GA_PRODUCTION DPB1(3.03922); HLA-DPA1(3.0355); HLA-DQB1(2.97025); HLA-DQA1(2.94591); HLA-DRB1(2.76738); HLA-DOA(2.72508); IL6(1.94139); ITGA4(1.44516); MAP3K14(1.30259); CCR9(1.22105); IL15RA(1.1474); HLA-DRB3(0.760622); TNFRSF17(0.648255); ITGB7(0.641235); LTBR(0.629883); CXCL12(0.576547); CD80(0.436654); IL15(0.401945); ICOSLG(0.38944); IL4(0.324564); CD40(0.271072); TNFRSF13B(0.134187); HLA-DRB4(0.0708609); IL5(0.0659333); CD86(0.049911); TNFSF13(0.0381369); ICOS(-0.029109); TNFRSF13C(- 0.0470145); TGFB1(-0.0624259); CCL27(-0.06631); CD28(-0.16103); IL10(- 0.165903); MADCAM1(-0.215493); AICDA(-0.228457); CCR10(-0.298206); CCL25(-0.310412); TNFSF13B(-0.330192); CXCR4(-0.338466); CCL28(- 0.446852); PIGR(-0.736478); REACTOME_INTERFERON_ 63 59 6.87752 3.04E-12 3.80E-10 HLA-DRB5(4.11028); IRF4(3.50609); HLA-G(3.2749); HLA-DQA2(3.16347); HLA- GAMMA_SIGNALING DPB1(3.03922); HLA-DPA1(3.0355);

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    36 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us